B-lymphopoiesis is stopped by mobilizing doses of G-CSF and is rescued by overexpression of the anti-apoptotic protein Bcl2.
Winkler, Ingrid G
B-lymphopoiesis is stopped by mobilizing doses of G-CSF and is rescued by overexpression of the anti-apoptotic protein Bcl2. [electronic resource] - Haematologica Mar 2013 - 325-33 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1592-8721
10.3324/haematol.2012.069260 doi
Animals
B-Lymphocyte Subsets--drug effects
Benzylamines
Bone Marrow--drug effects
Cyclams
Cyclophosphamide--pharmacology
Gene Expression
Granulocyte Colony-Stimulating Factor--administration & dosage
Hematopoietic Stem Cell Mobilization
Heterocyclic Compounds--pharmacology
Lymphopoiesis--drug effects
Male
Mice
Precursor Cells, B-Lymphoid--drug effects
Proto-Oncogene Proteins c-bcl-2--genetics
Spleen--drug effects
Tumor Necrosis Factor-alpha--antagonists & inhibitors
B-lymphopoiesis is stopped by mobilizing doses of G-CSF and is rescued by overexpression of the anti-apoptotic protein Bcl2. [electronic resource] - Haematologica Mar 2013 - 325-33 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1592-8721
10.3324/haematol.2012.069260 doi
Animals
B-Lymphocyte Subsets--drug effects
Benzylamines
Bone Marrow--drug effects
Cyclams
Cyclophosphamide--pharmacology
Gene Expression
Granulocyte Colony-Stimulating Factor--administration & dosage
Hematopoietic Stem Cell Mobilization
Heterocyclic Compounds--pharmacology
Lymphopoiesis--drug effects
Male
Mice
Precursor Cells, B-Lymphoid--drug effects
Proto-Oncogene Proteins c-bcl-2--genetics
Spleen--drug effects
Tumor Necrosis Factor-alpha--antagonists & inhibitors